Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Conraux, Laurence, Pech, Catherine, Guerraoui, Halim, Loyaux, Denis, Ferrara, Pascual, Guillemot, Jean-Claude, Meininger, Vincent, Pradat, Pierre-François, Salachas, François, Bruneteau, Gaëlle, Le Forestier, Nadine, Lacomblez, Lucette
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2013
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://ncbi.nlm.nih.gov/pubmed/24224000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079733
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים